These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4134042)

  • 41. [Principles of anticoagulant therapy in myocardial infarct].
    Krug H
    Pol Tyg Lek; 1972 Mar; 27(13):498-501. PubMed ID: 4553473
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 43. [New therapeutic trends in myocardial infarct. Preliminary data on long-term treatment with fibrinolytic agents in angiopathic patients].
    Molino N
    Cardiol Prat; 1967 Oct; 18(5):51-7. PubMed ID: 4179097
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
    Wojczuk J
    Wiad Lek; 1974 May; 27(10):877-82. PubMed ID: 4134634
    [No Abstract]   [Full Text] [Related]  

  • 45. Anticoagulants updated--application in coronary artery disease.
    Robinson DS
    Cardiovasc Clin; 1974; 6(2):9-22. PubMed ID: 4613466
    [No Abstract]   [Full Text] [Related]  

  • 46. Heparin and cancer.
    Zacharski LR; Ornstein DL
    Thromb Haemost; 1998 Jul; 80(1):10-23. PubMed ID: 9684778
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-induced inhibition of tumour cell dissemination.
    Burrage K; Hellmann K; Salsbury AJ
    Br J Pharmacol; 1970 May; 39(1):205P-206P. PubMed ID: 5420103
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of substances that increase the activity of the anti-coagulating system of tumor-bearing animals on the growth of metastases and on the ultrastructure of the metastatic cells].
    Kudriashov BA; Kolomina SM; Chentsov IuS; Kalishevskaia TM; Pogodina LS
    Vopr Onkol; 1977; 23(12):77-81. PubMed ID: 146306
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral anticoagulant therapy of human cancer.
    Thornes RD
    J Med; 1974; 5(1):83-91. PubMed ID: 4598771
    [No Abstract]   [Full Text] [Related]  

  • 50. Antithrombotic therapy in cancer.
    Lemoine NR
    J Clin Oncol; 2005 Apr; 23(10):2119-20. PubMed ID: 15699474
    [No Abstract]   [Full Text] [Related]  

  • 51. [The use of anticoagulants in the chemotherapy of cancer].
    Grekh IF; Shats VIa
    Vopr Onkol; 1969; 15(1):111-6. PubMed ID: 4891306
    [No Abstract]   [Full Text] [Related]  

  • 52. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 53. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
    Ojiro M
    Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of iron-dextran and ironfree colloid on the distribution of experimental metastases].
    Domellöf L; Boeryd B
    Nord Med; 1970 Oct; 84(42):1348-9. PubMed ID: 5479549
    [No Abstract]   [Full Text] [Related]  

  • 56. Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formation.
    Lindahl AK
    Curr Opin Lipidol; 1994 Dec; 5(6):434-9. PubMed ID: 7712048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of cancer cell stickiness by the blocking of platelet aggregation.
    Gastpar H
    S Afr Med J; 1974 Mar; 48(15):621-7. PubMed ID: 4823720
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of cerebrovascular thrombosis with plasmin and plasminogen activators.
    Meyer JS; Herndon RM; Johnson JF; Barnhart M
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():373-98. PubMed ID: 4224934
    [No Abstract]   [Full Text] [Related]  

  • 59. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR; Nazareth RA; Mourão PA
    Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis].
    Kalishevskaia TM; Golubeva MG; Bashkov GV; Vinter VB
    Fiziol Zh (1978); 1988; 34(3):88-93. PubMed ID: 2842201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.